Swizton Medtech articles

Preventive Cardiology: Early Detection for Better Heart Health

info@swiztonmedtech.com (Swizton Medtech) — Thu, 29 Oct 2026 06:30:00 GMT

Heart diseases develop silently for decades before the first symptom appears. Preventive cardiology shifts the focus to identifying cardiovascular risk early, giving you the power to act before it becomes an emergency.

Risk is cumulative

Standard cardiovascular risk is rarely driven by a single factor. It is the cumulative effect of many daily and biological factors. While an inherent risk from your family history is set as a genetic baseline, lifestyle choices such as diet, exercise, stress and smoking dictate how it occurs. Uncontrolled blood pressure causes strain on arterial walls while elevated cholesterol can build plaque, and unmanaged blood sugar damages the lining of blood vessels [1][2][3].

Digital health is changing prevention

Today, advances in digital healthcare are moving at a faster pace than before, transforming preventive cardiology, enabling faster detection, smarter risk assessment, and a more personalized roadmap to better heart care. Bringing healthcare to your fingertips has always been the driving force behind HeartIQ Score. It combines relevant clinical information and cardiovascular biomarkers to support a comprehensive approach to preventive heart health, helping individuals understand their cardiovascular risk and take informed steps toward prevention.

What advanced biomarkers add

Advanced blood biomarkers such as ApoB, Lp(a), and hs-CRP, when interpreted alongside lifestyle and other clinical factors, can help healthcare professionals develop a more comprehensive understanding of an individual’s cardiovascular risk [4]. When a potential high risk is identified, it provides both the patient and healthcare professionals an unprecedented opportunity to consider appropriate lifestyle changes, monitoring, further evaluation or treatment where clinically indicated.

Early knowledge creates an opportunity to act — this is the fundamental principle of preventive cardiology.

Protecting your heart shouldn’t begin in an emergency room. By taking a proactive approach today, you move away from guesswork. HeartIQ Score isn’t just a readout of lab numbers, it is your personal roadmap to a healthier and longer life.

Don’t wait for your symptoms to speak. Take control of your cardiac health today by discovering your score at www.heartiqscore.com.

References

Kim H. L., et al. (2023). Arterial stiffness and hypertension. Clinical Hypertension, 29(1), 31. doi:10.1186/s40885-023-00258-1
Hoffman M. (2023, March 19). Cholesterol and artery plaque buildup (M. Cassoobhoy, Med. Rev.). WebMD. webmd.com
National Institute of Diabetes and Digestive and Kidney Diseases. Diabetes, heart disease, & stroke. National Institutes of Health, U.S. Department of Health and Human Services. niddk.nih.gov
Meng Q., et al. (2024). Lp(a) and high-sensitivity C-reactive protein are predictive biomarkers for coronary heart disease in Chinese patients with type 2 diabetes mellitus. Heliyon, 10(21), e40074. doi:10.1016/j.heliyon.2024.e40074

Beyond the Standard Lipid Panel: How HeartIQ Score Uses Advanced Biomarkers for Heart Risk Assessment

info@swiztonmedtech.com (Swizton Medtech) — Wed, 28 Oct 2026 06:30:00 GMT

For decades, we relied on a very simple formula to check our heart health – checking our cholesterol levels and measuring blood pressure. Here is the reality: nearly half of all heart attacks occur in people way before they notice any anomalies.

Standard blood tests only show a part of the larger picture. HeartIQ Score takes a multidimensional approach to preventive cardiology by combining core vitals, advanced lipid profiling, genetic flags, and kidney-metabolic health into one comprehensive profile. Let’s look at the specific metrics that HeartIQ tracks and how they work together to protect your cardiovascular system.

1. Lipid particle analysis

Traditional tests measure the weight of cholesterol in your blood, but HeartIQ analyzes the particle counts and balance to assess true arterial risk. By measuring advanced biomarkers, HeartIQ captures vital information about your inherited cardiovascular risk, hidden inflammation and metabolic profile to make a better assessment of your health.

Apolipoprotein B (Apo B): Every single plaque-causing particle in your bloodstream (LDL, VLDL and IDL) carries exactly one Apo B molecule. Measuring Apo B therefore helps estimate the potential plaque-forming particles on your arterial highway, making it a far more accurate predictor of heart disease than standard LDL cholesterol alone [1].

LDL cholesterol measures the amount of cholesterol carried by LDL particles, whereas ApoB helps estimate the number of atherogenic particles circulating in the blood. When these measures differ, particularly in people with elevated triglycerides or metabolic conditions, ApoB can provide additional information to help clinicians assess cardiovascular risk [5].

Apolipoprotein A1 (Apo A1): Apo A1 is the primary protein component of HDL (“good”) cholesterol, responsible for clearing excess cholesterol from arterial walls and carrying it back to the liver [1].

Apo B / Apo A1 ratio: By evaluating the ratio of damaging Apo B particles to protective Apo A1 particles, HeartIQ can measure the balance between plaque buildup and plaque clearance [2].

Standard lipid panel (HDL, LDL, VLDL, triglycerides, total cholesterol): Provides the foundational baseline of total lipid volume and circulating fats in your blood.

2. Underlying threats & genetic flags

Heart disease risk is often inherited or driven by vascular inflammation, aspects that standard cholesterol panels may not capture.

Lipoprotein(a) [Lp(a)]: Often called the “silent genetic risk factor,” high Lp(a) is an inherited trait that accelerates arterial clotting and plaque formation regardless of diet or lifestyle. HeartIQ flags high Lp(a) early so preventive measures can be put in place [3].

hs-CRP (high-sensitivity C-reactive protein): Elevated hs-CRP signals systemic inflammation in the vascular lining, which can make arterial plaques unstable and prone to rupturing [3].

3. Metabolic & kidney integration

Your heart does not work in isolation. Metabolic health and kidney function directly influence arterial strain.

HbA1c: It measures average blood glucose over the past 3 months. Chronic elevation damages the delicate inner lining of blood vessels (the endothelium), making it easier for Apo B particles to stick and build plaque [4].

Creatinine (serum): It can present an overall picture of kidney function. Early kidney strain or impaired filtration increases strain on the blood vessels. Chronic kidney issues are an independent risk factor in cardiac health.

4. Real-time cardiovascular vitals

Blood pressure & pulse rate: Resting blood pressure and heart rate provide immediate data and overall health status.

Rather than some numbers on a page, HeartIQ transforms static lab results into a personalized, proactive roadmap of prevention.

Once your results are ready, our doctors can guide you through your personalized report, right from the comfort of your home. You can also take control of your cardiac health today with a simple sign up at www.heartiqscore.com.

References

Parish S., et al. (2009). The joint effects of apolipoprotein B, apolipoprotein A1, LDL cholesterol, and HDL cholesterol on risk: 3510 cases of acute myocardial infarction and 9805 controls. European Heart Journal, 30(17), 2137–2146. doi:10.1093/eurheartj/ehp221
Yusuf S., et al. (2004). Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case-control study. Lancet, 364(9438), 937–952. doi:10.1016/S0140-6736(04)17018-9
Mayo Clinic. Heart disease: In-depth guide to prevention and management. mayoclinic.org
BMC Nephrology. (2013). Association of HbA1c and cardiovascular and renal disease in an adult Mediterranean population. BMC Nephrol, 14, 151. link.springer.com
American Heart Association. (2026). 2026 Guideline on the Management of Dyslipidemia: Top things to know. AHA Professional Heart Daily. professional.heart.org

Looking Beyond Lifestyle: Understanding Inherited Heart Risk

info@swiztonmedtech.com (Swizton Medtech) — Tue, 27 Oct 2026 06:49:51 GMT

Heart disease does not always result from lifestyle choices alone. Family history and inherited factors can influence cardiovascular risk, sometimes even when cholesterol levels and other routine health measurements appear normal.

How does family history influence heart risk?

A family history of early cardiovascular disease can indicate an increased risk. Having a first-degree relative — a parent or sibling — who developed cardiovascular disease before age 55 in men or 65 in women is recognized as a cardiovascular risk-enhancing factor [1].

This association may reflect inherited tendencies towards high cholesterol, high blood pressure, diabetes, and other risk factors, alongside shared lifestyle habits. Family history does not mean heart disease is inevitable, but it can help identify people who may benefit from earlier risk assessment and preventive care.

What is Lipoprotein(a) [Lp(a)]?

Lipoprotein(a), or Lp(a), is a cholesterol-carrying particle in the blood that resembles LDL cholesterol but contains an additional protein called apolipoprotein(a). Its level is largely determined by genetics, and elevated Lp(a) is associated with an increased risk of atherosclerotic cardiovascular disease, including heart attack and stroke [2].

Importantly, Lp(a) can be elevated even when LDL cholesterol is within the recommended range. This means a routine lipid profile may not reveal the full picture of inherited cardiovascular risk.

Why should you consider Lp(a) testing?

Lp(a) is particularly relevant for people with a family history of premature heart disease or known elevated Lp(a). Major cardiovascular guidelines identify levels of 50 mg/dL or 125 nmol/L and above as a risk-enhancing factor [1, 2]. These units are not directly interchangeable using a single fixed conversion.

Because Lp(a) levels are largely inherited and generally remain relatively stable throughout life, measuring them can help identify an additional risk factor that may otherwise go unnoticed. A healthcare professional can advise whether testing is appropriate and how the result should be interpreted alongside other risk factors.

Understand your inherited risk. Take informed action.

Family history and Lp(a) are important pieces of the cardiovascular risk picture, but neither determines an individual’s future on its own. Understanding them alongside blood pressure, cholesterol, blood sugar, lifestyle and medical history can help guide a more informed prevention plan.

HeartIQ Score Application, developed by leading cardiologists in Kerala, brings together relevant health history, lifestyle factors and blood biomarkers, including Lipoprotein(a) [Lp(a)], to support cardiovascular risk assessment. By connecting risk assessment with online doctor consultations and personalized guidance, HeartIQ Score helps users better understand their cardiovascular risk and make informed decisions about preventive care.

From risk assessment to informed action — a pathway to better understand your heart health and take appropriate preventive steps.

Understand your heart risk now at www.heartiqscore.com.

References

Arnett D. K., et al. (2019). 2019 ACC/AHA Guideline on the Primary Prevention of Cardiovascular Disease. Circulation, 140, e596–e646. doi:10.1161/CIR.0000000000000678
Kronenberg F., et al. (2022). Lipoprotein(a) in atherosclerotic cardiovascular disease and aortic stenosis: a European Atherosclerosis Society consensus statement. European Heart Journal, 43(39), 3925–3946. doi:10.1093/eurheartj/ehac361

CAC vs. CCTA vs. CAG

info@swiztonmedtech.com (Swizton Medtech) — Mon, 26 Oct 2026 09:42:04 GMT

When it comes to evaluating and diagnosing heart health, not all scans are equal. If you or a loved one has ever experienced being on the other side, you might have encountered a maze of medical acronyms: CAC, CCTA (or CTCA) and CAG.

Even though they might sound the same, and though they check out the same coronary arteries, they serve different purposes using different methods. Let’s dive into what each scan is and why modern preventive cardiologists rely on CCTA to catch heart disease before they strike.

CAC scan – Coronary Artery Calcium scan

A fast, low radiation, non-contrast CT scan. It detects calcified or hardened plaque on the walls of your coronary arteries.
The result is a numerical score from 0 to 1000+ called the Agatston score.
The main catch is that the scan is only visible to calcified plaque and completely blind to “soft” and non-calcified plaque – the exact type of plaque prone to sudden rupture. As a result, a CAC score of zero does not completely exclude coronary artery disease, since non-calcified plaque can’t be measured using this test.
CAC scores also don’t directly determine the percentage of artery blockage. Results should be interpreted with age, sex, symptoms and other risk factors.

CCTA – Coronary Computed Tomography Angiography

An advanced non-invasive 3D CT scan performed with an intravenous contrast dye that visualizes the arterial lumen – the vessel wall.
It detects calcified plaque, soft vulnerable plaque, percentage of arterial blockage (stenosis) and provides the full view unlike CAC.
The procedure can help identify certain types of plaques that may not be detected by calcium scoring.
Unlike conventional CAG, which primarily visualizes the artery lumen, CCTA visualizes plaque outside the lumen that may not be apparent from CAG alone.

CAG – Conventional Coronary Angiography

An invasive procedure where a catheter is inserted to inject dye into the heart and record real-time blood flow.
It is mainly used in acute or high-risk cardiac situations to assess severe blockages and immediate interventions.

Why is CCTA preferred in preventive cardiology?

Major guidelines (ACC/ESC) suggest CCTA as the primary non-invasive scan over CAC and CAG [1][2]. Unlike a zero-calcium score, CCTA detects non-calcified “soft” plaque that allows clinicians to start preventive therapy before blockages form [3]. It also acts as an accurate non-invasive procedure, measuring total plaque burden and mapping vessel health while sparing patients with unnecessary invasive catheterization.
2024 ESC Guidelines for the Management of Chronic Coronary Syndromes support CCTA as a first-line diagnostic test and can give more accurate information for appropriately selected patients with suspected coronary artery disease [4].

When it comes to cardiac care, early detection is the key. By identifying vulnerable plaque and hidden inflammation early, you can take targeted action long before a blockage ever forms.

HeartIQ Score Application, developed with inputs from leading cardiologists in Kerala, combines advanced technologies, brings together relevant health history of person, lifestyle factors and blood biomarker testing, to perform cardiovascular risk assessment. By connecting risk assessment with online doctor consultations and personalized guidance, HeartIQ Score helps users better understand their cardiovascular risk and make informed decisions about preventive care in consultation with a doctor.

Start your personalized HeartIQ Score assessment today at www.heartiqscore.com.

References

Vrints C., et al. (2024). 2024 ESC Guidelines for the management of chronic coronary syndromes. European Heart Journal, 45(36), 3415–3537. doi:10.1093/eurheartj/ehae177
Gulati M., et al. (2021). 2021 AHA/ACC/ASE/CHEST/SAEM/SCCT/SCMR Guideline for the Evaluation and Diagnosis of Chest Pain. Journal of the American College of Cardiology, 78(22), e187–e285. doi:10.1016/j.jacc.2021.07.053
Smettei O., et al. (2025). Coronary artery calcium score of zero does not rule out obstructive CAD in young adults. American Heart Journal Plus: Cardiology Research and Practice, 62, 100707. doi:10.1016/j.ahjo.2025.100707
European Society of Cardiology. (2024). 2024 ESC Guidelines for the Management of Chronic Coronary Syndromes. European Heart Journal. academic.oup.com

A Journey through HeartIQ Score

info@swiztonmedtech.com (Swizton Medtech) — Sun, 25 Oct 2026 06:30:00 GMT

Ever spent hours sitting in a hospital waiting room or waiting days just to get your blood test results back? Managing your heart’s health shouldn’t be that exhausting.

At HeartIQ, we have redesigned the entire system from the ground up by combining doorstep blood sample collection across Kerala, digital reports and online specialist consultations for a personalized roadmap for your cardiovascular health.

Here is how HeartIQ brings end-to-end preventive cardiology straight to your doorstep.

Digital health assessment

Your journey begins with a simple digital health assessment that will take up just 3 minutes of your day. In just those 3 minutes, you provide crucial information regarding:

Personal lifestyle factors (sleep, activity level, smoking…)
Personal and family history of cardiovascular diseases [1]
Existing symptoms or medical conditions

At-home sample collection

Next, you can opt and schedule for your blood test directly through our platform. Our trusted lab partners will arrive right at your doorstep for blood sample collection, anywhere in Kerala and other participating locations outside Kerala. No travel. No waiting. Get your blood test done from the comfort of your home.

Unlike basic cholesterol tests, HeartIQ measures 9 cardiac biomarkers and vitals:

Advanced lipids & particle balance: Apo B, Apo A1, standard lipids (HDL, LDL, VLDL, triglycerides, total cholesterol) [2]
Inflammation & inherited risk factors: hs-CRP, Lipoprotein(a) [Lp(a)]
Metabolic & kidney health: HbA1c (assesses blood sugar control), serum creatinine (assesses kidney function)
Hemodynamic vitals: blood pressure, pulse rate

Personalized HeartIQ Score & cardiovascular risk assessment

Once the processing is done, log in to access your results including your blood test report and your personalized HeartIQ report. Knowing your HeartIQ Score is the first step towards true cardiovascular risk assessment.

Your health assessment, relevant risk factors and blood test biomarkers are considered together to generate a unified HeartIQ Score, to categorize your data into a single, actionable risk category: Low, Medium, or High Risk.

Your HeartIQ Score helps you understand your heart risk, identify key risk factors and take preventive action through lifestyle changes and timely medical guidance. Your score helps you understand your risk profile, but it does not diagnose coronary artery blockages. Wait for the next step – doctor consultation.

Complimentary doctor consultation

Data is only valuable when paired with expert clinical guidance. Every user receives a free initial online consultation with our doctors at their preferred date and time.

The doctor reviews your complete HeartIQ profile and determines the optimal next steps:

Direct imaging recommendation: The doctor may recommend cardiac CT scanning directly based on your risk profile.
Cardiologist referral: In certain cases, the doctor can refer you directly to an online cardiologist consultation. The cardiologist will then evaluate your overall profile and decide on the next steps — whether to prescribe targeted medications, order cardiac imaging, or schedule routine follow-ups.

Targeted CT scanning & post-scan cardiologist consultation

If imaging is recommended, your consulting doctor will select the cardiac imaging or coronary artery tests tailored to your risk profile:

CAC (Coronary Artery Calcium): For quick baseline calcification scoring.
CCTA (Coronary CT Angiography): For high-definition 3D mapping of both hard and soft (non-calcified) plaque.

You can book your scan online at your preferred date and time with our partner imaging centers across Kerala. Once your scan results are uploaded to the platform, you can go for a free follow-up cardiologist consultation to review the scan, optimize medications, and establish your personalized long-term preventive plan.

Cardiologist review & guidance

Following a Coronary Calcium Score or CCTA, the results are reviewed by a cardiologist along with your HeartIQ Score, symptoms, medical history, and other risk factors. The cardiologist provides personalized guidance on the next steps, which may include lifestyle changes, risk-factor management, medication, regular monitoring, or further cardiac evaluation, depending on the findings. The aim is to turn test results into a clear, personalized plan for long-term heart health and prevention.

Managing your cardiac health shouldn’t involve endless hospital queues or guesswork. From doorstep blood collection to specialist consultations and imaging coordination, HeartIQ brings preventive cardiology directly to you.

A unique proposition from HeartIQ Score

HeartIQ is designed to make preventive cardiac care accessible, affordable and actionable by combining technology, clinical guidance and cost-effective diagnostics:

Convenient access: blood sample collection and appointments from the comfort of your home
Blood investigations – available at discounted rates
HeartIQ Score assessment & doctor consultation – currently free with no additional charges
Post-CCTA cardiology consultation – currently free with no additional charge
CCTA – available at discounted rates
Continuous evaluation and support – personalized heart care by experienced and renowned cardiologists

Start your HeartIQ Score assessment today at www.heartiqscore.com.

References

Arnett D. K., et al. (2019). 2019 ACC/AHA Guideline on the Primary Prevention of Cardiovascular Disease: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. Circulation, 140(11), e596–e646. doi:10.1161/CIR.0000000000000678
Blumenthal R. S., et al. (2026). 2026 ACC/AHA/AACVPR/ABC/ACPM/ADA/AGS/APhA/ASPC/NLA/PCNA Guideline on the Management of Dyslipidemia: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines. Journal of the American College of Cardiology, 87(19), 2624–2757. doi:10.1016/j.jacc.2025.11.016

Rethinking Cardiac Risk: Beyond Traditional Heart Risk Score

info@swiztonmedtech.com (Swizton Medtech) — Sat, 24 Oct 2026 06:30:00 GMT

One can assume a common question in our minds, when it comes to our cardiovascular health, is “What is my risk of having a heart attack?”. The answer for the same historically relied on statistical calculators called cardiovascular risk scores.

While traditional scoring systems served as crucial stepping stones for 20th-century medicine, many were developed decades ago using western population data. Today, as advanced biomarkers, ethnic-specific risk research, and non-invasive imaging reshape preventive cardiology, we have a long way to go — and that’s how the HeartIQ Score was developed as a way for preventive cardiology.

Let’s break down the most common cardiac risk scores and how HeartIQ Score can better support you.

PREVENT

A newer cardiovascular risk prediction framework developed by the American Heart Association. This model incorporates cardiovascular, kidney function and metabolic health factors to estimate cardiovascular risk. HbA1c is an optional predictor in the relevant model [2].

Disadvantages: Although PREVENT incorporates a broader range of health measures, blood tests like ApoA1, ApoB, Lipoprotein(a), hs-CRP and family history are not considered in its core equations.

QRISK3 or SCORE2

Updated regional models used extensively in the UK (QRISK3) and Europe (SCORE2) that incorporate additional factors like kidney disease and social deprivation. They account for broader systemic health conditions and ethnicity multipliers.

Disadvantages: Still bound by traditional lipid panels; fail to account for inherited genetic traits like Lipoprotein(a), ApoA1, ApoB, hs-CRP, HbA1c, family history etc.

Reynolds Risk Score

Incorporates conventional risk factors and additional information, including hs-CRP and family history of premature heart attack in some versions [1].

Disadvantages: The model does not directly incorporate inherited genetic traits like Lipoprotein(a), or the extent of family history.

Framingham Risk Score (FRS)

The Framingham Risk Score estimates 10-year cardiovascular risk based on age, sex, total cholesterol, HDL, blood pressure, smoking, and diabetes status. It established the foundation of modern preventive cardiology and is easy to calculate with routine labs [3].

Disadvantages: Heavily weighted by age; ignores advanced markers like ApoA1, ApoB, Lipoprotein(a), hs-CRP etc. and history of heart risks.

ASCVD Risk Estimator (AHA/ACC Pooled Cohort Equations)

A widely used, established risk calculator used by the American Heart Association to guide statin therapy for primary prevention. It is better calibrated for broader demographic groups compared to early Framingham models. The 2026 AHA/ACC dyslipidemia guideline now recommends PREVENT rather than PCE for primary-prevention lipid-lowering decisions.

Disadvantages: Evaluates only a 10-year window rather than lifetime risk; relies on standard LDL weight rather than atherogenic particle counts (ApoB); misses silent vascular inflammation (hs-CRP) and inherited genetic traits like Lipoprotein(a).

What is HeartIQ Score?

Traditional risk calculators were set for a time when doctors had access to basic cholesterol panels and blood pressure values. Today, we have tools to find hidden inflammation, specific risks, and vascular changes long before symptoms appear.

HeartIQ combines personal health information, lifestyle factors, medical history, advanced cardiac biomarkers and clinical assessment to provide personalized risk assessment, risk-based insights, and preventive guidance.

Health assessment – A questionnaire covering medical history, family history and lifestyle factors.
Blood tests – Assess relevant biomarkers, including cholesterol, ApoB, ApoA1, Lp(a), hs-CRP and HbA1c. Home sample collection is available through the program’s laboratory arrangements.
Heart risk assessment – HeartIQ analyses the collected information to classify cardiovascular risk as Low, Intermediate or High.
Online doctor consultation – Discuss the results and understand the recommended next steps with a doctor.
Further evaluation, if needed – Additional tests such as CCTA or CAC may be recommended based on risk score and clinical assessment. This enables targeted cardiac evaluation based on risk, rather than routine CT angiography for everyone.
Preventive care – Follow appropriate medical advice and preventive measures to manage cardiovascular risk.

The HeartIQ Score combines advanced technologies into a unified, actionable assessment. While traditional scores stop at static lab numbers, HeartIQ uses scores to guide imaging and online consultations to create a seamless pathway.

From risk assessment to informed action, HeartIQ helps users understand their risk, access professional guidance and make informed decisions about preventive care.

Discover your cardiovascular risk profile today at www.heartiqscore.com.

References

Ridker P. M., et al. (2008). C-Reactive Protein and Parental History Improve Global Cardiovascular Risk Prediction: The Reynolds Risk Score for Men. Circulation, 118, 2243–2251. pmc.ncbi.nlm.nih.gov
American Heart Association. PREVENT Equations: Cardiovascular Risk Assessment. AHA Professional Heart Daily. professional.heart.org
Framingham Heart Study. Cardiovascular Disease: 10-Year Risk. Framingham Heart Study Research Resources. framinghamheartstudy.org